Healthcare provider profile · identity verified

Rabiah Ali, M.D.

Internal Medicine · SEATTLE, WA · NPI 1780002170

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	930	225
Amlodipine Besylate	Amlodipine Besylate	669	176
Levothyroxine Sodium	Levothyroxine Sodium	635	144
Sertraline Hcl	Sertraline Hcl	485	109
Lisinopril	Lisinopril	443	119
Losartan Potassium	Losartan Potassium	437	111
Gabapentin	Gabapentin	421	108
Omeprazole	Omeprazole	376	88
Metoprolol Succinate	Metoprolol Succinate	354	100
Quetiapine Fumarate	Quetiapine Fumarate	308	37
Furosemide	Furosemide	290	77
Trazodone Hcl	Trazodone Hcl	278	72
Simvastatin	Simvastatin	252	67
Tamsulosin Hcl	Tamsulosin Hcl	234	54
Memantine Hcl	Memantine Hcl	227	42
Mirtazapine	Mirtazapine	217	38
Duloxetine Hcl	Duloxetine Hcl	205	49
Eliquis	Apixaban	201	45
Rosuvastatin Calcium	Rosuvastatin Calcium	200	54
Donepezil Hcl	Donepezil Hcl	193	46
Metformin Hcl	Metformin Hcl	186	46
Pantoprazole Sodium	Pantoprazole Sodium	178	44
Hydrochlorothiazide	Hydrochlorothiazide	162	49
Famotidine	Famotidine	152	34
Escitalopram Oxalate	Escitalopram Oxalate	142	24
Carvedilol	Carvedilol	140	31
Finasteride	Finasteride	140	30
Allopurinol	Allopurinol	130	34
Metformin Hcl Er	Metformin Hcl	127	42
Alendronate Sodium	Alendronate Sodium	121	29
Myrbetriq	Mirabegron	117	23
Albuterol Sulfate Hfa	Albuterol Sulfate	114	49
Potassium Chloride	Potassium Chloride	105	25
Buspirone Hcl	Buspirone Hcl	104	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	102	27
Clopidogrel	Clopidogrel Bisulfate	89	23
Hydralazine Hcl	Hydralazine Hcl	83	20
Pravastatin Sodium	Pravastatin Sodium	83	24
Citalopram Hbr	Citalopram Hydrobromide	82	16
Fluoxetine Hcl	Fluoxetine Hcl	79	24
Xarelto	Rivaroxaban	79	22
Spironolactone	Spironolactone	78	17
Metoprolol Tartrate	Metoprolol Tartrate	77	21
Lovastatin	Lovastatin	74	18
Atenolol	Atenolol	69	20
Glimepiride	Glimepiride	67	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	67	15
Ropinirole Hcl	Ropinirole Hcl	62	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	60	17
Baclofen	Baclofen	57	11
Torsemide	Torsemide	55	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	54	13
Diclofenac Sodium	Diclofenac Sodium	52	13
Alprazolam	Alprazolam	51	22
Aripiprazole	Aripiprazole	48	13
Cephalexin	Cephalexin	48	22
Ezetimibe	Ezetimibe	47	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	47	20
Venlafaxine Hcl Er	Venlafaxine Hcl	46	suppressed
Benazepril Hcl	Benazepril Hcl	45	suppressed
Bupropion Hcl Sr	Bupropion Hcl	45	suppressed
Synthroid	Levothyroxine Sodium	44	14
Tramadol Hcl	Tramadol Hcl	43	11
Jardiance	Empagliflozin	42	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	42	suppressed
Fluticasone Propionate	Fluticasone Propionate	41	20
Ozempic	Semaglutide	41	14
Bupropion Xl	Bupropion Hcl	39	suppressed
Ipratropium Bromide	Ipratropium Bromide	39	15
Tizanidine Hcl	Tizanidine Hcl	38	suppressed
Montelukast Sodium	Montelukast Sodium	37	15
Estradiol	Estradiol	35	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	33	suppressed
Oxycodone Hcl	Oxycodone Hcl	32	15
Prednisone	Prednisone	31	19
Nystatin	Nystatin	30	18
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	30	suppressed
Arnuity Ellipta	Fluticasone Furoate	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Dutasteride	Dutasteride	27	suppressed
Labetalol Hcl	Labetalol Hcl	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	11
Gemtesa	Vibegron	26	suppressed
Glipizide	Glipizide	26	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	16
Lidocaine	Lidocaine	26	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Meloxicam	Meloxicam	25	suppressed
Primidone	Primidone	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	14
Ketoconazole	Ketoconazole	24	12
Lansoprazole	Lansoprazole	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	23	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Lorazepam	Lorazepam	22	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Spiriva Respimat	Tiotropium Bromide	21	suppressed
Celecoxib	Celecoxib	20	suppressed
Risperidone	Risperidone	20	suppressed
Glipizide Er	Glipizide	19	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	19	suppressed
Methenamine Hippurate	Methenamine Hippurate	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Pregabalin	Pregabalin	18	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Oxycontin	Oxycodone Hcl	17	suppressed
Solifenacin Succinate	Solifenacin Succinate	17	suppressed
Bupropion Hcl	Bupropion Hcl	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Dilt-Xr	Diltiazem Hcl	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Nadolol	Nadolol	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Topiramate	Topiramate	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Clotrimazole	Clotrimazole	15	suppressed
Colchicine	Colchicine	15	suppressed
Diazepam	Diazepam	15	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Liothyronine Sodium	Liothyronine Sodium	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Amantadine	Amantadine Hcl	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Scopolamine	Scopolamine	13	suppressed
Verapamil Sr	Verapamil Hcl	13	suppressed
Azithromycin	Azithromycin	12	11
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	12	suppressed
Lamotrigine Er	Lamotrigine	12	suppressed
Probenecid	Probenecid	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Carbamazepine Er	Carbamazepine	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Galantamine Er	Galantamine Hbr	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Mirabegron Er	Mirabegron	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error